BRISBANE, Australia, Dec. 19, 2023 (GLOBE NEWSWIRE) — Allkem Limited (ASX and TSX: AKE, “Allkem”) refers to the proposed merger of equals between Allkem and Livent Corporation (“Livent”), (“Transaction”).
Further to Allkem’s announcement on 19 December 2023 that the requisite majorities of Allkem shareholders have voted in favour of the proposed scheme of arrangement (“Scheme”), Allkem is pleased to announce that Livent stockholders have now approved the adoption of the Transaction Agreement and the transactions contemplated by it.
The approval by Livent stockholders satisfies a key condition to implementation of the Transaction.
As announced by Allkem on 14 December 2023, the Second Court Hearing to approve the Scheme is scheduled to be held at 2:15 pm (AWST) today (Wednesday, 20 December 2023). Allkem shareholders should refer to Allkem’s ASX announcement “Allkem Shareholders vote in favour of merger with…
